The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners
Official Title: One Plus One Can Be Greater Than Two: Ecological Momentary Assessment for Black Prostate Cancer Survivors and Partners
Study ID: NCT04189770
Brief Summary: This trial studies the day-to-day stress, social support, and health lifestyle behaviors (such as physical activity and nutrition) in African American patients with stage 0-III prostate cancer survivors and their partners. How patients cope with stress may affect their lifestyle behaviors. This study may help understand not only survivors' behaviors but also partners' behaviors and how they interact.
Detailed Description: PRIMARY OBJECTIVES: I. Examine temporal associations between dyadic coping and health behaviors such as physical activity and diet. II. Identify social and physical contexts in which health behaviors occur/co-occur among survivors and their partners. EXPLORATORY OBJECTIVE: I. Investigate potential moderators for the associations between stress and dyadic coping. OUTLINE: Patients and partners complete questionnaires over 60 minutes about demographic information, stress, coping, and lifestyle behaviors at baseline and end of study. Patients and partners also receive an accelerometer and complete Ecological Momentary Assessment (EMA) questionnaire on stress, coping, physical activity, and eating behaviors over 5-10 minutes four time daily (QID; 7:30 am, 11:30 am, 3:30 pm, and 7:30 pm) via an smartphone application (app) for 14 days. Patients and partners also complete a survey on nutrition twice weekly (BIW) for a total of 4 surveys.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
M D Anderson Cancer Center, Houston, Texas, United States
Name: Dalnim Cho
Affiliation: M.D. Anderson Cancer Center
Role: PRINCIPAL_INVESTIGATOR